Lupus Journal

Overview

publication venue for

• Salmonella septic arthritis of the knees in a patient with systemic lupus erythematosus. 2013
• Longitudinal myelitis in patient with systemic lupus erythematosus, homozygous prothrombin G20210A and heterozygous MTHFR 677T. 2007
• Familial antiphospholipid antibodies and acquired circulating anticoagulants. 2004
• Extensive lymphadenopathy as the first clinical manifestation in systemic lupus erythematosus. 2000
• Fever and pneumonia in a steroid treated patient with systemic lupus erythematosus. 2000
• COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)..  30. 2021
• Impact of the first wave of the COVID-19 pandemic on systemic lupus erythematosus patients: Results from a multi-center prospective cohort..  30. 2021
• 16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome..  30. 2021
• A prospective study of reproductive factors in relation to risk of systemic lupus erythematosus among black women..  30. 2020
• Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry..  29. 2020
• Dietary patterns and risk of systemic lupus erythematosus in women..  29. 2019
• Longitudinal evaluation of diffusion tensor imaging and cognition in systemic lupus erythematosus..  27. 2018
• Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome..  27. 2018
• Feasibility of Patient-Reported Outcomes Measurement Information System (PROMIS®) computerized adaptive tests in systemic lupus erythematosus outpatients..  27. 2018
• Long-term survival of kidney grafts in lupus nephritis: a Mexican cohort..  27. 2018
• Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease..  27. 2017
• The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus..  25. 2016
• Short-term patient-centered nutrition counseling impacts weight and nutrient intake in patients with systemic lupus erythematosus..  24. 2015
• Systemic lupus erythematosus is not a risk factor for poor outcomes after total hip and total knee arthroplasty..  24. 2015
• Effects of obesity on health-related quality of life in juvenile-onset systemic lupus erythematosus..  24. 2014
• Assisted reproductive technology in SLE and APS..  23. 2014
• Contraception in patients with systemic lupus erythematosus and antiphospholipid syndrome..  23. 2014
• Social capital: a novel platform for understanding social determinants of health in systemic lupus erythematosus..  24. 2014
• A new trick for an ancient drug: quinine dissociates antiphospholipid immune complexes..  24. 2014
• Anti-C1q antibodies in systemic lupus erythematosus..  24. 2014
• A surge in anti-dsDNA titer predicts a severe lupus flare within six months..  23. 2013
• Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I..  22. 2013
• Site differences in mild cognitive dysfunction (MCD) among patients with systemic lupus erythematosus (SLE)..  22. 2013
• A pilot study of office-based spirometry in patients with systemic lupus erythematosus..  21. 2012
• APS ACTION--AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking..  21. 2012
• Administration of fasudil, a ROCK inhibitor, attenuates disease in lupus-prone NZB/W F1 female mice..  21. 2012
• 'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010..  20. 2011
• Antiphospholipid Syndrome Clinical Research Task Force report..  20. 2011
• Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies..  20. 2011
• Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions..  20. 2011
• Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations..  20. 2011
• Perceptions and measurements of physical activity in patients with systemic lupus erythematosus..  20. 2010
• Non-criteria manifestations of antiphospholipid syndrome..  19. 2010
• Moderate versus high-titer persistently anticardiolipin antibody positive patients: are they clinically different and does high-titer anti-beta 2-glycoprotein-I antibody positivity offer additional predictive information?.  19. 2009
• Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies..  18. 2009
• A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus..  18. 2009
• Lack of association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adults..  18. 2009
• Do children with lupus have fewer male siblings?.  17. 2008
• Relationship of quality of life and physical function measures with disease activity in children with systemic lupus erythematosus..  14. 2005
• Autoimmunity, infertility and assisted reproductive technologies..  13. 2004
• Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus..  13. 2004
• Quality of life in paediatric lupus..  13. 2004
• Activation of complement mediates antiphospholipid antibody-induced pregnancy loss..  12. 2003
• On being a Kunkel acolyte..  12. 2003
• Dual antibody reactivity to beta2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome..  11. 2002
• Practice patterns of antiphospholipid syndrome at a tertiary teaching hospital in Lebanon..  11. 2002
• Reporting consistency in systemic lupus erythematosus patients: how reliable are patient histories?.  11. 2002
• FcgammaRIIa/IIIa polymorphism and its association with clinical manifestations in Korean lupus patients..  10. 2001
• Increased cervical dysplasia in intravenous cyclophosphamide-treated patients with SLE: a preliminary study..  9. 2000
• Assessing disease activity in SLE patients during pregnancy..  8. 1999
• Gender, biology and human disease: report of a conference..  8. 1999
• Why women?.  6. 1997
• Antiphospholipid antibodies activate vascular endothelial cells..  5. 1996
• Antiphospholipid antibody: future developments..  3. 1994
• Antiphospholipid antibodies differ in aPL cofactor requirement..  1. 1992
• Belimumab in primary antiphospholipid syndrome. 2016
• Simple screening tool for assessing attention deficit in pediatric lupus. 2015
• Lupus anticoagulant--hypoprothrombinemia syndrome and pregnancy. 2001
• International consensus for a definition of disease flare in lupus. 2010
• Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report. 2003
• Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. 2003
• Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies. 2003
• Treatment of pregnant patients with antiphospholipid syndrome. 2003
• Grand rounds from international lupus centres. 1997
• Images of lupus: diving for pearls..  9. 2000
• Why do patients with antiphospholipid antibody clot?.  6. 1997
• Does lupus flare during pregnancy?.  2. 1993
• The clinical significance of low complement levels in patients with catastrophic antiphospholipid syndrome: A descriptive analysis of 73 patients from the "Catastrophic antiphospholipid syndrome registry". 2022
• C3 glomerulonephritis and systemic lupus erythematosus: A report of a patient treated with eculizumab and review of the literature. 2021
• 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends. 2020
• 16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. 2020
• The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. 2015
• Diet, microbiota and autoimmune diseases. 2014
• Ultraviolet radiation and systemic lupus erythematosus. 2014
• The interferon-alpha signature of systemic lupus erythematosus. 2010
• Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet? 2010
• The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis. 2010
• Cranial nerve VI palsy as a rare initial presentation of systemic lupus erythematosus: case report and review of the literature. 2009
• Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome. 2008
• New developments in lupus-associated antiphospholipid syndrome. 2008
• Pathogenic role of antiphospholipid antibodies. 2008
• The innate immune system in SLE: type I interferons and dendritic cells. 2008
• Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials. 2007
• Quality of life in children with systemic lupus erythematosus: a review. 2007
• Systemic lupus erythematosus in children: current and emerging therapies. 2007
• Sex differences in autoimmune disease. 2006
• Cardiac involvement in the antiphospholipid syndrome. 2005
• New insights into complement: a mediator of injury and marker of disease activity in systemic lupus erythematosus. 2004
• Studies of autologous T cell activation in the Kunkel laboratory. 2003
• Protein-losing enteropathy in systemic lupus erythematosus: report of a severe, persistent case and review of pathophysiology. 2002
• Sex ratio and rheumatic disease: excerpts from an Institute of Medicine report. 2002
• A genomic approach to scoliosis pathogenesis. 1999
• Lupus anticoagulant-hypoprothrombinemia syndrome associated with systemic lupus erythematosus: report of 2 cases and review of literature. 1999
• Pregnancy loss and antiphospholipid antibodies. 1998
• Pathogenesis of the antiphospholipid antibody syndrome. 1996
• Significance of aPL IgG subclasses. 1996
• Antiphospholipid antibodies and placental anticoagulant protein I. 1994
• Role of transforming growth factor beta (TGF beta) in systemic autoimmunity. 1993

Identity

ISO Abbreviation

• Lupus

Linking ISSN

• 0961-2033

International Standard Serial Number (ISSN)

• 0961-2033

Electronic International Standard Serial Number (EISSN)

• 1477-0962